| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |